Top compounds associated with response to NMRK2


Feature Type Standardized
Nominal ANOVA
mRNA Sunitinib FIMM pan-cancer AAC -0.43 0.01
mRNA UNC1215 GDSC1000 pan-cancer AAC 0.09 0.01
mRNA YK 4-279 GDSC1000 pan-cancer AAC -0.097 0.01
mRNA BRD-K51831558 CTRPv2 pan-cancer AAC 0.13 0.01
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.084 0.01
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.084 0.02
mRNA Doxorubicin gCSI pan-cancer AAC -0.12 0.02
mRNA PD-0332991 GDSC1000 pan-cancer AAC -0.083 0.02
mRNA NSC-207895 GDSC1000 pan-cancer AAC 0.08 0.02
mRNA PF-750 CTRPv2 pan-cancer AAC 0.085 0.02
Download CSV